Breaking news

SAP Surpasses Novo Nordisk To Become Europe’s Largest Company

SAP, the German software company, has officially overtaken Danish pharmaceutical giant Novo Nordisk to become Europe’s largest company by market capitalization. SAP’s market value reached $340 billion, surpassing Novo Nordisk’s $293.06 billion.

Key Factors Behind SAP’s Rise

SAP has experienced significant stock growth, particularly driven by optimism around its cloud business and its investments in generative artificial intelligence (AI). Since the start of 2025, SAP’s shares have risen 7%, and the company has seen a total return of 160% since the end of 2022, substantially outpacing the broader European STOXX 600 index, which rose by only 28%. The company’s increasing focus on cloud technologies and AI solutions for business applications has positioned it as a leader in digital transformation.

In recent months, strong investor interest has further propelled SAP’s growth, spurred by its expanding cloud services portfolio, AI developments, and strategic partnerships with large international corporations. These factors, alongside improvements to SAP’s ERP systems, have helped the company secure its top position.

Challenges For Novo Nordisk

In contrast, Novo Nordisk, which held the title of Europe’s largest company as recently as September 2023, has seen its stock lag due to disappointing results from its experimental obesity drug, Cagrisema. This has led to a slight decline in its market value, despite its strong performance in the pharmaceutical industry.

What This Means For The Future

The rise of SAP highlights the growing dominance of the technology sector in Europe, with digital transformation and AI solutions becoming key areas of investor focus. While Novo Nordisk is likely to remain a major player in the pharmaceutical industry, SAP’s success suggests that the European technology sector could experience even more growth, particularly with the increasing importance of AI and automation in business.

Looking ahead, competition between tech giants such as SAP and ASML is expected to intensify, marking the beginning of a new era for Europe’s technology-driven economy.

Cyprus Livestock Industry Navigates Hemorrhagic Fever Impact

The recent outbreak of hemorrhagic fever has stirred concern among professionals in the livestock sector. Industry insiders report a modest 10% increase in lamb prices, while both production and export volumes of halloumi remain resilient.

Market Dynamics And Price Adjustments

Kostas Leivadotius, President of the Pan-Cypriot Meat Retailers Association, said supply has tightened following movement restrictions. Lamb prices increased from about €11 to €12 after detection of the virus, while pork and beef prices remain unchanged.

Production And Slaughter Statistics

Leivadotius said around 700,000 animals are slaughtered annually in Cyprus, including approximately 20,000 cattle, 450,000 pigs, and 200,000 lambs, with additional supply covered through imports. During last year’s Easter period, more than 50,000 lambs were processed.

Logistical Challenges And Regulatory Responses

Movement restrictions are affecting transport and processing of livestock. Leivadotius said slaughterhouse operations have been disrupted, prompting discussions with authorities on measures to improve transport and processing efficiency.

Regional Implications And Import Adjustments

Following reported cases on Lesvos, Cyprus suspended imports of meat from the area. Imports from Lesvos are typically limited, but alternative supply sources are now being considered.

Maintaining Production Amid Health Concerns

Emphasizing the need for decisive action, Leivadotius urged industry stakeholders and the wider public to heed expert guidance on disease containment. He underlined that accelerated vaccination efforts and stringent movement controls are essential to curb the spread of the virus, thereby allowing production levels to return to normal.

Stability In Halloumi Exports

Michalis Koullouros, representative of the Cyprus Cheese Producers Association, said halloumi exports and prices remain stable, with producers continuing to meet domestic and international demand. Around 80% of Cyprus’ milk production is used for halloumi, with exports accounting for €350 million of a €400 million market. He added that significant livestock losses could affect production levels if the situation worsens.

Future Considerations And Industry Priorities

Looking ahead, industry experts remain watchful of the potential reevaluation of the Protected Designation of Origin (PDO) timeline for halloumi. Although discussions on revising the current schedule have not yet taken center stage, the primary focus now is on containing the outbreak and reinforcing support for livestock producers. This strategy is essential for restoring production and ensuring the industry’s long-term viability.

In summary, while the outbreak of hemorrhagic fever has led to some immediate market adjustments, decisive regulatory action and industry resilience may well steer Cyprus’ livestock and dairy sectors back on track in the near future.

Aretilaw firm
Uol
The Future Forbes Realty Global Properties
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter